Marc Roper

Marc Roper has extensive experience in sales within the biopharmaceutical industry, particularly in the field of biologics. From September 2017 to March 2021, Marc served as a Senior Executive Biologics Sales Specialist at AstraZeneca, where responsibilities included promoting Tezspire for Severe Uncontrolled Asthma, achieving a national ranking of 30th out of 180 in 2022. Prior to this role, Marc worked at Genentech from September 2014 to September 2017, holding positions such as Senior Clinical Specialist and Division Manager while contributing to the successful launch of Esbriet for Idiopathic Pulmonary Fibrosis. Marc's brief tenure as a Pulmonary Sales Specialist at InterMune began in September 2014. Marc holds a Bachelor's Degree in Health from the University of Richmond, graduating in 1995, and attended Hingham High School from 1987 to 1991.